RhythMedix Acquisition (January 2024)
Pharos Capital acquired majority stake in RhythMedix, a leading cardiac remote patient monitoring platform, expanding our healthcare technology portfolio
Recent Portfolio News & Achievements
Sanderling Renal Services Growth
Portfolio company Sanderling continues expansion of dialysis and renal telemedicine services to underserved rural communities, including new home dialysis programs
Vantage Surgical Solutions Expansion (2023)
Vantage acquired Ophthalmic Surgical Solutions and launched Vantage Clear, strengthening position in ophthalmology and cataract surgery markets
Professional Profiles
Bloomberg Profile
View Bob Crants III's executive profile on Bloomberg, including career history and Pharos Capital leadership
View on Bloomberg →Connect with Bob Crants III on LinkedIn for healthcare investment insights and industry updates
View on LinkedIn →Pharos Capital Group
Official biography and role as Founding Partner & Chief Investment Officer at Pharos Capital
View on Pharos →Active Portfolio Companies
Healthcare Technology
- RhythMedix - Cardiac remote patient monitoring
- Verdi Oncology - Oncology services platform
- Technology-enabled care coordination platforms
- Remote monitoring and telehealth solutions
Specialty Care Services
- Sanderling Renal Services - Dialysis & renal care
- Vantage Surgical Solutions - Ophthalmology services
- THEMA Health Services - Hospice & palliative care
- Rural and underserved market focus
Investment Focus Areas
- Value-based care models
- Healthcare services & technology
- Middle-market growth companies
- $25-50M typical investment size
Geographic Presence
- Dallas, TX - Primary headquarters
- Nashville, TN - Secondary office
- Portfolio companies nationwide
- Focus on underserved communities
Pharos Capital Group Impact
1998
Founded by Bob Crants III
$900M+*
Assets Under Management
27
Years in Operation
$1.495B
Funds Raised Since Inception
As Founding Partner and Chief Investment Officer, Bob Crants III co-founded Pharos Capital Group alongside Dr. Kneeland Youngblood in 1998. The physician-founded firm specializes in value-based healthcare investments that improve patient outcomes while generating strong returns, with a particular focus on underserved rural and urban communities across America.
Speaking & Advisory
Bob Crants III is available for select speaking engagements and advisory roles focused on healthcare investment, value-based care, and improving healthcare access in underserved markets.
Key Speaking Topics:
- The Future of Healthcare Private Equity
- Building Sustainable Healthcare Businesses in Rural Markets
- Value-Based Care: From Theory to Practice
- Healthcare Innovation and Technology Adoption
- ESG Principles in Healthcare Investment
- Creating Social Impact Through Private Capital
Media Inquiries
For media inquiries, interview requests, or speaking engagements, please contact: